Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-156629
Filing Date
2023-05-30
Accepted
2023-05-30 16:29:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d496018d424b3.htm 424B3 513029
2 GRAPHIC g496018dsp107.jpg GRAPHIC 3431
3 GRAPHIC g496018dsp108.jpg GRAPHIC 2322
4 GRAPHIC g496018g0527015652762.jpg GRAPHIC 6608
  Complete submission text file 0001193125-23-156629.txt   531590
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262339 | Film No.: 23976874
SIC: 2834 Pharmaceutical Preparations